Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: Report of a case

Surgery Today

Volumn 41, Issue 4, 2011, Pages 591-595

  Deniz, Kemal ^a   Torun, Edip ^a   Çelikbilek, Mehmet ^a   Sözüer, Erdoǧan ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Cholangiocarcinoma; Etiology; Hepatocellular carcinoma; Hepatolithiasis; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL PAIN; ADULT; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE DUCT STONE; CASE REPORT; CHOLECYSTECTOMY; CHOLELITHIASIS; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FEVER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER HISTOLOGY; LIVER RESECTION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LITHIASIS; LIVER DISEASES; LIVER NEOPLASMS; MIDDLE AGED; RISK FACTORS;

EID: 79956227547     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4290-4     Document Type: Article

References (21)

1. Tazuma S. Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol 2006;20:1075-83. (Pubitemid 44774809)
2. Wittekind C, Fischer HP, Ponchon T. Combined hepatocellular- cholangiocarcinoma. In: Hamilton SR, Aaltonen LA, editors. WHO classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 181.
3. Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004;40:298-304. (Pubitemid 38115836)
4. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol 1949;25:647-55.
5. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985;55:124-35.
6. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002;94:2040-6. (Pubitemid 34270058)
7. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanché H, Franco D, et al. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 2004;41: 292-8.
8. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular- cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998;13:34-40. (Pubitemid 28137756)
9. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 2006;13:537-42. (Pubitemid 46766710)
10. Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 2003;138:86-90. (Pubitemid 36055656)
11. Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, et al. Genetic classification of combined hepatocellularcholangiocarcinoma. Hum Pathol 2000;31:1011-7.
12. Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, et al. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 2009;16:623-9.
13. Nakamura S, Suzuki S, Sakaguchi T, Serizawa A, Konno H, Baba S, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer 1996;78:1671-6. (Pubitemid 26330894)
14. Sasaki A, Kawano K, Aramaki M, Ohno T, Tahara K, Takeuchi Y, et al. Clinicopathologic study of mixed hepatocellular and cholangiocellular carcinoma: modes of spreading and choice of surgical treatment by reference to macroscopic type. J Surg Oncol 2001;76:37-46. (Pubitemid 32128361)
15. Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003;33:283-7. (Pubitemid 43115254)
16. Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005;189:120-5. (Pubitemid 40215518)
17. Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 2005;20:759-64. (Pubitemid 40733372)
18. Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, et al. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007;6:161-5. (Pubitemid 46546995)
19. Kassahun WT, Hauss J. Management of combined hepatocellular carcinoma and cholangiocarcinoma. Int J Clin Pract 2008;62:1271-8. (Pubitemid 351977606)
20. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-25. (Pubitemid 38738341)
21. Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular- cholangiocarcinoma: A western experience. Ann Surg Oncol 2008;15:1880-90.